Sartorius Stedim Biotech SA (SDMHF)
254.56
+10.46
(+4.29%)
USD |
OTCM |
Oct 29, 16:00
Sartorius Stedim Biotech Net Income (Quarterly) : 110.91M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 110.91M |
| June 30, 2026 | 108.95M |
| March 31, 2026 | 103.07M |
| December 31, 2025 | 54.94M |
| September 30, 2025 | 75.61M |
| June 30, 2025 | 77.81M |
| March 31, 2025 | 89.88M |
| December 31, 2024 | 49.39M |
| September 30, 2024 | 28.89M |
| June 30, 2024 | 52.32M |
| March 31, 2024 | 61.76M |
| December 31, 2023 | 35.59M |
| September 30, 2023 | 38.08M |
| June 30, 2023 | 144.86M |
| March 31, 2023 | 119.63M |
| December 31, 2022 | 193.50M |
| September 30, 2022 | 202.66M |
| June 30, 2022 | 228.50M |
| March 31, 2022 | 303.34M |
| December 31, 2021 | 7.783M |
| September 30, 2021 | 172.57M |
| June 30, 2021 | 179.13M |
| March 31, 2021 | 154.29M |
| December 31, 2020 | 114.45M |
| September 30, 2020 | 118.68M |
| Date | Value |
|---|---|
| June 30, 2020 | 74.34M |
| March 31, 2020 | 83.18M |
| December 31, 2019 | 61.15M |
| September 30, 2019 | 65.71M |
| June 30, 2019 | 73.15M |
| March 31, 2019 | 64.15M |
| December 31, 2018 | 77.66M |
| September 30, 2018 | 57.92M |
| June 30, 2018 | 60.38M |
| March 31, 2018 | 50.88M |
| December 31, 2017 | 52.11M |
| September 30, 2017 | 44.13M |
| June 30, 2017 | 44.35M |
| March 31, 2017 | 43.38M |
| December 31, 2016 | 37.26M |
| September 30, 2016 | 49.55M |
| June 30, 2016 | 44.94M |
| March 31, 2016 | 40.79M |
| December 31, 2015 | 27.25M |
| September 30, 2015 | 45.46M |
| June 30, 2015 | 36.92M |
| March 31, 2015 | 21.92M |
| December 31, 2014 | 24.15M |
| September 30, 2014 | 26.50M |
| June 30, 2014 | 25.78M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Bruker Corp. | -50.90M |
| Azenta, Inc. | -1.529M |
| Danaher Corp. | 1.207B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 876.81M |
| Total Expenses (Quarterly) | 766.94M |
| EPS Diluted (Quarterly) | 1.129 |
| Enterprise Value | 27.21B |
| Gross Profit Margin (Quarterly) | 44.99% |
| Profit Margin (Quarterly) | 12.65% |
| Earnings Yield | 1.52% |
| Operating Earnings Yield | 2.67% |
| Normalized Earnings Yield | 1.749 |